Anbio Biotechnology
NNNN
$6.61
$0.040.61%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.80M | 1.80M | 366.50K | 366.50K | 760.30K |
| Total Depreciation and Amortization | -- | -- | 1.60K | 1.60K | 4.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.10K | -69.10K | -73.50K | -73.50K | -8.20K |
| Change in Net Operating Assets | -1.43M | -1.43M | -911.30K | -911.30K | 309.30K |
| Cash from Operations | 299.50K | 299.50K | -616.60K | -616.60K | 1.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.10K | 69.10K | 73.50K | 73.50K | 791.60K |
| Cash from Investing | 69.10K | 69.10K | 73.50K | 73.50K | 791.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.00 | 100.00 | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -57.50K | -57.50K | 106.50K | 106.50K | -127.90K |
| Cash from Financing | -57.40K | -57.40K | 106.50K | 106.50K | -127.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 311.20K | 311.20K | -436.60K | -436.60K | 1.73M |